Carecloud Stock Price, News & Analysis
Company Description
CareCloud, Inc. (associated with the preferred stock ticker CCLDP) is a healthcare technology company focused on AI-powered and technology-enabled solutions for medical practices, hospitals, integrated health systems, and other healthcare organizations. The company is described in multiple press releases as a leader in healthcare technology, generative AI solutions, and AI-driven platforms that support financial performance, clinical workflows, and patient experience.
CareCloud’s business centers on delivering a suite of solutions that help clients increase financial and operational performance, streamline clinical workflows, and reduce administrative burdens and operating costs. According to the company’s disclosures, more than 40,000 to 45,000 providers rely on CareCloud’s platform to improve patient care while managing the business side of healthcare more efficiently.
Core solutions and platform focus
Across its public communications, CareCloud highlights a portfolio that includes revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence (BI), patient experience management (PXM), digital health, and dedicated artificial intelligence (AI) offerings. These solutions are described as AI and technology-enabled, with an emphasis on helping clients manage reimbursement, scheduling, documentation, analytics, and patient engagement.
The company also references an AI Center of Excellence, which is tasked with driving product innovation and applying generative AI and other advanced models across inpatient and ambulatory EHR, RCM, analytics, and patient engagement. In several news releases, CareCloud characterizes its platform as bringing “disciplined innovation” and generative AI to the business of healthcare, reinforcing its focus on operational and financial outcomes for healthcare providers.
AI-driven products and recent expansions
CareCloud’s news flow highlights specific AI-driven products and recent strategic moves. One example is stratusAI Desk Agent, described as an agentic AI phone receptionist that modernizes and automates patient phone interactions. According to the company, this product manages high-volume calls and supports workflows such as appointment scheduling, rescheduling, cancellations, call triage and routing, prescription refill request processing, referral and authorization intake, responses to lab result questions and common FAQs, and pre-visit instructions and reminders. It is positioned as a 24/7, no-wait phone access solution that uses conversational AI integrated with EHR and PM systems.
CareCloud also references stratusAI Voice Audit, a conversational intelligence platform that, when combined with stratusAI Desk Agent, provides visibility into call monitoring, quality scoring, trends in call volumes and service levels, AI-driven performance metrics, and insights into patient sentiment, intent, and unmet needs. Together, these tools are described as forming an AI-powered phone ecosystem for patient access and operational oversight.
Another notable component of the portfolio is Wellsoft, an emergency department information system (EDIS) that entered the CareCloud product set through the acquisition of Medsphere. In company communications, Wellsoft is described as an emergency-grade clinical workflow platform with clinical depth and usability, designed for fast triage, high-acuity documentation, and structured decision support. CareCloud positions Wellsoft as suitable for emergency departments and urgent care settings, with capabilities around throughput, staffing efficiency, integrated diagnostics, and ancillary services.
Acquisitions and hospital market strategy
CareCloud’s filings and press releases describe a strategy that includes acquisitions to expand its reach, particularly in the hospital and inpatient software markets. The company reports that a newly created indirect subsidiary, CareCloud Holdings, Inc., entered into an Asset Purchase Agreement to acquire certain assets of Medsphere Systems Corporation, a provider of healthcare IT software and related services to the U.S. inpatient and ambulatory market. The transaction involved cash and a deferred payment agreement secured by company assets.
In addition, CareCloud announced the acquisition of HFMA’s MAP App, a hospital benchmarking tool developed by the Healthcare Financial Management Association. MAP App is described as a tool for benchmarking and measuring revenue cycle management performance, used by hospitals and healthcare organizations. Through this acquisition and a long-term joint marketing agreement, CareCloud plans to expand MAP App’s capabilities with AI-driven insights and integrate it into its broader revenue cycle platform.
Financial profile and capital structure context
CareCloud’s public filings include condensed consolidated financial statements and details on its capital structure. The company reports net revenue, operating income, adjusted EBITDA, and other metrics, and has discussed achieving multiple consecutive quarters of positive GAAP net income. It has also disclosed guidance ranges for revenue, adjusted EBITDA, and earnings per share for its fiscal year, along with commentary about profitable growth, operational discipline, and integration of acquisitions.
CareCloud has preferred stock securities, including Series A Cumulative Redeemable Perpetual Preferred Stock and Series B Cumulative Redeemable Perpetual Preferred Stock. The company has issued communications about dividend policies, including periods of suspended dividends, reinstatement of monthly dividends, and a plan to pay double monthly dividends on Series B Preferred Stock to address accumulated dividend arrears. The company also describes redemption terms for Series B Preferred Stock, with specified redemption prices and conditions, and notes that dividends are cumulative and payable monthly.
In a press release concerning preferred stock dividends, the company explains that due to the mandatory conversion of the Series A Preferred Stock into common stock on March 6, 2025, the Series A Preferred Stock was delisted from the Nasdaq Global Market because the security no longer met continued listing requirements. The communication notes that the company may, at its option and subject to notice requirements, redeem additional shares of Series A Preferred Stock for cash at a stated redemption price plus any accumulated and unpaid dividends.
Trading and listings
In its press releases, CareCloud states that its common stock and certain preferred stock series trade on the Nasdaq Global Market under the symbols CCLD and CCLDO for the Series B Preferred Stock. The description of CCLDP is tied to the company’s Series A Preferred Stock, which underwent a mandatory conversion into common stock and was subsequently delisted from Nasdaq as a separate security. These details position CCLDP as part of the historical capital structure associated with CareCloud’s preferred equity rather than an actively traded ongoing preferred series.
Operational footprint and governance disclosures
CareCloud’s SEC filings list its principal executive offices in Somerset, New Jersey, and provide a telephone number for the registrant. The company has disclosed changes in its independent registered public accounting firm, including the resignation of a prior firm due to staffing capacity limitations related to SOX Section 404(b) requirements and the appointment of a new firm. It has also reported on the termination of a previous secured revolving line of credit and the subsequent entry into a new line of credit agreement with another bank, secured by substantially all of the company’s assets.
Across these disclosures, CareCloud emphasizes regulatory compliance through timely filing of Form 8-K reports on material events, acquisitions, financing arrangements, dividend decisions, and auditor changes. These filings provide investors with insight into the company’s governance, financing strategy, and risk management around acquisitions and credit facilities.
Position within healthcare technology and AI
In multiple news releases, CareCloud describes itself as a leader in healthcare technology solutions, AI-driven healthcare technology solutions, and generative AI solutions for medical practices, health systems, hospitals, and integrated health systems nationwide. The company highlights its AI Center of Excellence and its focus on enterprise AI innovation across ambulatory and hospital markets. Its communications reference an expanding presence in the inpatient software market through acquisitions such as Medsphere and HFMA’s MAP App, as well as the integration of AI into acquired platforms to enhance performance and efficiency.
By combining EHR, RCM, practice management, analytics, patient experience tools, and AI-based products like stratusAI Desk Agent, CareCloud positions its platform as a way for healthcare organizations to connect clinical workflows with financial outcomes. While specific customer names are limited in public statements, the company notes that tens of thousands of providers use its solutions, indicating a broad installed base across various care settings.